# Paul McGale

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paul-mcgale/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,824 |
| Field | Breast Cancer Treatment Studies |
| h-index | 39 |
| i10-index | 50 |
| Last Known Institution | University of Oxford |
| OpenAlex ID | https://openalex.org/A5091277996 |
| ORCID iD | https://orcid.org/0009-0003-4112-3031 |
| Works | 88 |

## Researcher papers

- [Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials](https://scholariq.org/papers/effect-of-radiotherapy-after-breast-conserving-surgery-on-10-year-recurrence-and/)
- [Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials](https://scholariq.org/papers/long-term-outcomes-for-neoadjuvant-versus-adjuvant-chemotherapy-in-early-breast/)
- [Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden](https://scholariq.org/papers/incidence-of-heart-disease-in-35-000-women-treated-with-radiotherapy-for-breast/)
- [Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials](https://scholariq.org/papers/increasing-the-dose-intensity-of-chemotherapy-by-more-frequent-administration-or/)
- [Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials](https://scholariq.org/papers/trastuzumab-for-early-stage-her2-positive-breast-cancer-a-meta-analysis-of-13/)
- [Breast cancer survival in sub‐Saharan Africa by age, stage at diagnosis and human development index: A population‐based registry study](https://scholariq.org/papers/breast-cancer-survival-in-sub-saharan-africa-by-age-stage-at-diagnosis-and-human/)
- [Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials](https://scholariq.org/papers/anthracycline-containing-and-taxane-containing-chemotherapy-for-early-stage/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Chemotherapy-induced cardiotoxicity and mitigation](https://scholariq.org/topics/chemotherapy-induced-cardiotoxicity-and-mitigation/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)
- [Cancer Risks and Factors](https://scholariq.org/topics/cancer-risks-and-factors/)

## Researcher university

- [University of Oxford](https://scholariq.org/institutions/university-of-oxford/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.